Lymphedema After Urologic Surgery

NCT ID: NCT05264337

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-14

Study Completion Date

2030-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lymphedema of the extremities is common after lymph node surgery in treating several forms of cancer, e.g., breast cancer. However, very little is known of the occurrence of lymphedema of the lower extremities after urologic surgery with lymph node dissection. This project aims to describe the frequency and grade of lymphedema arising after urologic surgery, using the Lymphedema Quality of Life Questionnaire (LymQOL), Delfin MoistureMeter D, and lower limb volume measurements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Bladder Neoplasms Prostatic Neoplasms Testicular Neoplasms Penile Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Radical Cystectomy

Patients undergoing radical cystectomy with pelvic lymph node dissection for urinary bladder cancer

Self-reported lymphedema

Intervention Type OTHER

Lymphedema as reported by LymQOL questionnaire.

Dielectric constant ratio

Intervention Type OTHER

Measurement of percentage tissue water content of lower extremities by dielectric constant ratio measured by MoistureMeter D.

Limb volume

Intervention Type OTHER

Measurement of lymphedema by limb volume of lower extremities by multiple measurements of circumference.

Radical Prostatectomy

Patients undergoing radical prostatectomy with pelvic lymph node dissection for prostate cancer

Self-reported lymphedema

Intervention Type OTHER

Lymphedema as reported by LymQOL questionnaire.

Retroperitoneal

Patients undergoing retroperitoneal lymph node dissection for testicular cancer

Self-reported lymphedema

Intervention Type OTHER

Lymphedema as reported by LymQOL questionnaire.

Other

Patients undergoing other urologic surgery with lymph node dissection of inguinal, iliacal or retroperitoneal lymph nodes

Self-reported lymphedema

Intervention Type OTHER

Lymphedema as reported by LymQOL questionnaire.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Self-reported lymphedema

Lymphedema as reported by LymQOL questionnaire.

Intervention Type OTHER

Dielectric constant ratio

Measurement of percentage tissue water content of lower extremities by dielectric constant ratio measured by MoistureMeter D.

Intervention Type OTHER

Limb volume

Measurement of lymphedema by limb volume of lower extremities by multiple measurements of circumference.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing urologic surgery with lymph node dissection

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vastra Gotaland Region

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Henrik Kjölhede, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Sahlgrenska University Hospital, Gothenburg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sahlgrenska University Hospital

Gothenburg, , Sweden

Site Status RECRUITING

Örebro University Hospital

Örebro, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Henrik Kjölhede, MD, PhD

Role: CONTACT

+46-31-3421000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Henrik Kjölhede, MD PhD

Role: primary

+46-31-3421000

Peter Kirrander, MD PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-04840

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Use of Stem Cells in Lymphedema Post Mastectomy
NCT01112189 COMPLETED PHASE1/PHASE2